NASDAQ:MEDS TRxADE HEALTH (MEDS) Stock Price, News & Analysis → The Scary Fed Idea To Turn Your Dollars Into a Digital Power Grab (From Oasis Gold) (Ad) Free MEDS Stock Alerts $9.49 +0.25 (+2.71%) (As of 03:26 PM ET) Add Compare Share Share Today's Range$8.04▼$11.2750-Day Range$5.62▼$9.2452-Week Range$3.69▼$44.56Volume1.49 million shsAverage Volume274,140 shsMarket Capitalization$13.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get TRxADE HEALTH alerts: Email Address Ad WealthPressOptions expert shares his top option strategy for freeA 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time. For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades. That includes multiple big time winners like 82% from Adobe… 77% from Palo Alto… But also a barrage of smaller winners like 20% from AMC… Each of which were opened on a Friday afternoon and closed the very next Monday morning. As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend.Check it out, simply follow this link here. About TRxADE HEALTH Stock (NASDAQ:MEDS)TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.Read More MEDS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MEDS Stock News HeadlinesMay 29, 2024 | globenewswire.comTRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QMay 29, 2024 | yahoo.comSouthern Nevada Health District warns 'tranq' found in illegal drug supplyJune 18, 2024 | Priority Gold (Ad)Biden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...May 28, 2024 | yahoo.comSouthern Nevada Health District warns ‘tranq’ found in illegal drug supplyMay 28, 2024 | msn.comCourt outlines how Mass. man allegedly tricked ex into taking meds to end pregnancyMay 28, 2024 | msn.comRunning therapy matches antidepressants for mental health, surpasses for physical benefitsMay 16, 2024 | msn.comNew menopause drugs treat hot flashes, but women may face insurance hurdlesMay 3, 2024 | forbes.comBest Prostate Health Supplements Of 2024, According To ExpertsJune 18, 2024 | Priority Gold (Ad)Biden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...April 30, 2024 | msn.comWeight loss drugs like Wegovy have taken the country by storm. But who can afford them?April 28, 2024 | msn.comSemaglutide v. tirzepatide: What to know about popular weight loss and diabetes drugs like OzempicApril 27, 2024 | msn.comDEA wants your unused prescription medicationsApril 26, 2024 | msn.comDrug Take Back Day gives East Tennesseans the chance to dispose of unwanted prescription drugsApril 23, 2024 | globenewswire.comTRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-KApril 18, 2024 | msn.comLexington among cities with highest cost of prescription medications, study showsApril 17, 2024 | msn.comWhat Medications Can Cause Antiphospholipid Syndrome? A Review By DoctorsApril 17, 2024 | msn.comOn Your Side: Know this about flea and tick medicationsApril 11, 2024 | msn.comThis multifunctional system can send drugs where they can be effective in body’s tissues, organsApril 11, 2024 | msn.comHundreds of drugs are in short supply around the U.S., pharmacists warnApril 1, 2024 | msn.comZenCortex Review: 180 Days Evaluation – Does This Ear Health Supplement Really Work?March 31, 2024 | msn.comThese Common Medications Could Have Terrifying Side EffectsMarch 29, 2024 | msn.comMedicare increase in spending on diabetes drugs could cost seniors more moneyMarch 29, 2024 | msn.comPopular Medications That Can Make Your Muscles WeakMarch 12, 2024 | msn.comFAIR Meds Act could impact costs for prescriptionsMarch 12, 2024 | msn.comA massive cyberattack has some Arizona health providers reeling. Here's what we knowMarch 11, 2024 | msn.comTexas health centers awarded over $19 million in grantsMarch 11, 2024 | msn.comLexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare moversSee More Headlines Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/24/2021Dividend Payable3/22/2024Ex-Dividend for 3/22 Dividend3/25/2024Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryN/A Current SymbolNASDAQ:MEDS CUSIPN/A CIK1382574 Webwww.trxade.com Phone(800) 261-0281Fax800-265-6932Employees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($6.9388) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,840,000.00 Net Margins-215.72% Pretax Margin-165.87% Return on Equity-428.28% Return on Assets-116.96% Debt Debt-to-Equity Ratio0.05 Current Ratio0.24 Quick Ratio0.24 Sales & Book Value Annual Sales$8.27 million Price / Sales1.58 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book20.53Miscellaneous Outstanding Shares1,410,000Free Float725,000Market Cap$13.03 million OptionableNot Optionable Beta2.21 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)Founder, Chairman, CEO & Secretary Comp: $354.23kMr. Prashant Patel R.Ph. (Age 50)Founder, President, COO, Interim CFO, Interim Principal Financial & Accounting Officer and Director Comp: $147.04kDr. Ramesh KenchappaChief Scientific OfficerMr. David M. Saslow Esq.Inhouse CounselDr. Shafaat Pirani Pharm.D.Executive Vice President of Alliance Pharma Solutions, LLCKey CompetitorsBIMINASDAQ:BIMIHWH InternationalNASDAQ:HWHCosmos HealthNASDAQ:COSMMcKessonNYSE:MCKCencoraNYSE:CORView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 10,617 shares on 5/20/2024Ownership: 0.753%View All Institutional Transactions MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed in 2024? TRxADE HEALTH's stock was trading at $5.20 at the start of the year. Since then, MEDS stock has increased by 77.9% and is now trading at $9.25. View the best growth stocks for 2024 here. When is TRxADE HEALTH's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, June 24th 2024. View our MEDS earnings forecast. How were TRxADE HEALTH's earnings last quarter? TRxADE HEALTH, Inc. (NASDAQ:MEDS) released its quarterly earnings results on Sunday, October, 24th. The company reported ($2.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.95) by $0.45. The firm had revenue of $2.55 million for the quarter, compared to analyst estimates of $1.94 million. TRxADE HEALTH had a negative net margin of 215.72% and a negative trailing twelve-month return on equity of 428.28%. During the same quarter last year, the firm posted $0.30 earnings per share. How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH? TRxADE HEALTH declared a dividend on Wednesday, February 28th. Shareholders of record on Monday, March 18th will be given a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date is Monday, March 25th. Read our dividend analysis for MEDS. When did TRxADE HEALTH's stock split? TRxADE HEALTH's stock reverse split on the morning of Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of TRxADE HEALTH own? Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK), Alto Ingredients (PEIX), Tiziana Life Sciences (TLSA) and Trevena (TRVN). Who are TRxADE HEALTH's major shareholders? TRxADE HEALTH's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.75%). Insiders that own company stock include Donald G Fell, Michael L Peterson and Surendra K Ajjarapu. View institutional ownership trends. How do I buy shares of TRxADE HEALTH? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MEDS) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
